Public Relations
Managing Director: Eva Reynolds
Managing Director: Alison MacKenzie
4th Floor, Holborn Gate
26 Southampton Buildings
London WC2A 1AH
Google map
Telephone: +44 (0)20 7861 1600
Website: http://www.reynoldsmackenzie.com
Reynolds-MacKenzie boasts a formidable team of front-line, proactive campaign developers for the healthcare and pharmaceutical industry, offering everything you’d expect from an outstanding public relations agency, and a few things you might not.
Founded upon the realisation that the healthcare industry all too often does not achieve the results it expects, we work with our client brand teams to develop bespoke, tailored communications programmes based on grassroots stakeholder insights.
Committed in our approach to ensuring that both UK and international PR programmes deliver for our clients’ brands, Reynolds-MacKenzie is the creative force behind many high-impact healthcare campaigns of recent years. It’s our unparalleled expertise and our ability to look beyond the obvious that really sets us apart.
Our services include:
- Direct-to-consumer campaigns
- Global and national programming
- HTA communication management
- Internal communications
- Issues management
- Professional relations
- Media campaign development
- Media training
- Patient relations
- Advocacy development
- POM/OTC
- Strategic media counsel
Recent activities include:
- The UK media launch (August 2011) of the first ever licensed drug for the treatment of advanced skin cancer. We achieved coverage in every national media target and countless regional, 180 items of coverage in total. Achieving over 60 million OTS
- A spoof campaign for the charity SKCIN which tricked 250,000 people across the UK into believing in the miraculous tanning power of the fictitious cult tanning product from Sweden – Sunny 3. SKCIN wanted a campaign that engaged those most at risk, the 15-24+ age group
- Launched the first ever licensed medicine for the treatment of hepatitis C, on August 8th amidst the London riots. Despite the inhospitable media environment, we managed to achieve over 50 million OTS on the day
- The UK launch of the first ever licensed medicine for atrial fibrillation (aleading cause of stroke) saw phenomenal media reach (September 2011). Resulting in over 100 pieces of coverage and an OTS of over 80million. Highlights included almost every national newspaper front page of the Daily Express, a groundbreaking 12-page supplement in The Sunday Times reaching almost 2 million additional readers
Back to company list